Subcellular localization of KL-6 mucin in intraductal papillary mucinous neoplasm of the pancreas.

This study aimed to clarify the expression profile of KL-6 mucin in intraductal papillary mucinous neoplasm (IPMN) and its relation to tumor malignancy. Expression of KL-6 mucin in 38 IPMNs (intraductal papillary mucinous adenoma (IPMA), 24 cases; minimally invasive intraductal papillary mucinous carcinoma (MI-IPMC), 8 cases; invasive carcinoma originating from IPMC (IC-IPMC), 6 cases) and 66 pancreatic ductal adenocarcinomas (PDACs) was evaluated immunohistochemically. IC-IPMCs and MI-IPMCs had positive staining of KL-6 mucin whereas 58% of IPMAs tested negative. Subcellular localization of KL-6 mucin varied among IPMNs whereas all of the PDAC had positive expression in the circumferential membrane and cytoplasm of cancer cells. IC-IPMCs and MI-IPMCs had a higher frequency of circumferential membrane and cytoplasmic localization of KL-6 mucin than did IPMAs. These results suggest that localization of KL-6 mucin could be used to predict the malignancy of IPMN.

[1]  N. Kokudo,et al.  Expression of KL-6/MUC1 in pancreatic cancer tissues and its potential involvement in tumor metastasis. , 2011, Oncology reports.

[2]  S. Gendler,et al.  Pancreatic ductal adenocarcinoma mice lacking mucin 1 have a profound defect in tumor growth and metastasis. , 2011, Cancer research.

[3]  K. Mafune,et al.  Sustained aberrant localization of KL-6 mucin and beta-catenin at the invasion front of human gastric cancer cells. , 2011, Anticancer research.

[4]  M. Goto,et al.  Significance of mucin expression in pancreatobiliary neoplasms , 2010, Journal of hepato-biliary-pancreatic sciences.

[5]  Wei Tang,et al.  Clinicopathology of sialomucin: MUC1, particularly KL-6 mucin, in gastrointestinal, hepatic and pancreatic cancers. , 2009, Bioscience trends.

[6]  N. Hiraoka,et al.  Preoperative Evaluation of Invasive and Noninvasive Intraductal Papillary-Mucinous Neoplasms of the Pancreas: Clinical, Radiological, and Pathological Analysis of 123 Cases , 2009, Pancreas.

[7]  N. Kokudo,et al.  Effect of benzyl-N-acetyl-α-galactosaminide on KL-6 mucin expression and invasive properties of a human pancreatic carcinoma cell line. , 2008, Drug discoveries & therapeutics.

[8]  M. Makuuchi,et al.  Clinical significance of subcellular localization of KL-6 mucin in primary colorectal adenocarcinoma and metastatic tissues. , 2006, World journal of gastroenterology.

[9]  M. Makuuchi,et al.  KL-6 mucin expression in carcinoma of the ampulla of Vater: association with cancer progression. , 2005, World journal of gastroenterology.

[10]  Yuan-yuan Li,et al.  Expression of mucins and E-cadherin in gastric carcinoma and their clinical significance. , 2004, World journal of gastroenterology.

[11]  Koichi Suda,et al.  Cystic Neoplasm of the Pancreas: A Japanese Multiinstitutional Study of Intraductal Papillary Mucinous Tumor and Mucinous Cystic Tumor , 2004, Pancreas.

[12]  T. Irimura,et al.  Expression of Different Glycoforms of Membrane Mucin (MUC1) and Secretory Mucin (MUC2, MUC5AC and MUC6) in Pancreatic Neoplasms , 2003 .

[13]  J. Lüttges,et al.  The Mucin Profile of Noninvasive and Invasive Mucinous Cystic Neoplasms of the Pancreas , 2002, The American journal of surgical pathology.

[14]  M. Pasdar,et al.  The importance of MUC1 cellular localization in patients with breast carcinoma , 2001, Cancer.

[15]  T. Tsuchida,et al.  DF3 expression in human gallbladder carcinoma: significance for lymphatic invasion. , 2000, International journal of oncology.

[16]  S. Takao,et al.  MUC‐1 mucin expression in invasive areas of intraductal papillary mucinous tumors of the pancreas , 1998, Pathology international.

[17]  D. Ota,et al.  MUC1 mucin expression as a marker of progression and metastasis of human colorectal carcinoma. , 1994, Gastroenterology.

[18]  Y. S. Kim,et al.  Immunohistochemical study of mucin carbohydrates and core proteins in human pancreatic tumors , 1993, Cancer.

[19]  N. Peat,et al.  Molecular cloning and expression of human tumor-associated polymorphic epithelial mucin. , 1990, The Journal of biological chemistry.

[20]  S. Hakomori,et al.  Molecular changes in carbohydrate antigens associated with cancer , 1990, BioEssays : news and reviews in molecular, cellular and developmental biology.

[21]  N. Kohno,et al.  Detection of soluble tumor-associated antigens in sera and effusions using novel monoclonal antibodies, KL-3 and KL-6, against lung adenocarcinoma. , 1988, Japanese journal of clinical oncology.

[22]  P. Altevogt,et al.  Metastatic potential severely altered by changes in tumor cell adhesiveness and cell-surface sialylation , 1983, The Journal of experimental medicine.